Transforming Big Pharma addresses critically how strategy works in the pharmaceutical industry. John Ansell assesses the wide range of alternative strategies big pharma has been attempting in order to make up the shortfall in revenues stemming from the long-standing failure to develop sufficient new products. He shows that there is sound evidence t
Juni 2024, ca. 282 Seiten, Englisch
Taylor and Francis
978-1-03-283733-8
Taylor and Francis
978-1-03-283733-8